Together, these results demonstrate that HoxA5 is a novel and potent regulator of tissue angiogenesis, that may also have therapeutic efficacy in limiting tumor angiogenesis thereby impairing de novo tumor progression. The gene discussed is HOXA5; the disease is neoplasm.